BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Piotrowski-Daspit AS, Barone C, Lin CY, et al. (2022) In vivo correction of cystic fibrosis mediated by PNA nanoparticles. Science Advances. 8: eabo0522 |
| Luks VL, Mandl H, DiRito J, et al. (2022) Surface conjugation of antibodies improves nanoparticle uptake in bronchial epithelial cells. Plos One. 17: e0266218 |
| Ullrich SJ, Freedman-Weiss M, Ahle S, et al. (2021) Nanoparticles for Delivery of Agents to Fetal Lungs. Acta Biomaterialia |
| Egan ME. (2020) Emerging Technologies for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Restoration in all People with CF. Pediatric Pulmonology |
| Schupp JC, Khanal S, Gomez JL, et al. (2020) Single Cell Transcriptional Archetypes of Airway Inflammation in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine |
| Egan ME. (2020) Cystic fibrosis transmembrane conductance receptor modulator therapy in cystic fibrosis, an update. Current Opinion in Pediatrics. 32: 384-388 |
| Quinn RA, Melnik AV, Vrbanac A, et al. (2020) Global chemical effects of the microbiome include new bile-acid conjugations. Nature |
| Di Pietro C, Zhang PX, O'Rourke TK, et al. (2017) Ezrin links CFTR to TLR4 signaling to orchestrate anti-bacterial immune response in macrophages. Scientific Reports. 7: 10882 |
| Egan ME. (2017) Effects of Lumacaftor/Ivacaftor in a Pediatric Cohort Homozygous for F508del-CFTR. American Journal of Respiratory and Critical Care Medicine. 195: 849-850 |
| Knauf F, Thomson RB, Heneghan JF, et al. (2016) Loss of Cystic Fibrosis Transmembrane Regulator Impairs Intestinal Oxalate Secretion. Journal of the American Society of Nephrology : Jasn |